Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may lead to the downregulation of OR52B2 by promoting acetylation of histones, thereby changing the chromatin structure to a state that suppresses the initiation of transcription at the OR52B2 gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase activity, 5-Azacytidine could decrease methylation levels of the OR52B2 gene promoter, potentially reducing the binding of transcriptional repressors and leading to decreased OR52B2 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A may bind to specific DNA sequences upstream of OR52B2, obstructing the binding sites for transcriptional activators, leading to a reduction in OR52B2 transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could decrease OR52B2 expression through retinoic acid receptor-mediated repression of transcription factor activity that is essential for the initiation of OR52B2 transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has the potential to downregulate OR52B2 expression by altering the histone code at the OR52B2 promoter region, specifically by increasing the levels of histone marks associated with a closed chromatin state. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate might inhibit OR52B2 expression by hyperacetylating histones at the OR52B2 gene promoter, which can lead to the recruitment of transcriptional co-repressors that silence gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could decrease OR52B2 expression by altering the transcriptional machinery assembly at the OR52B2 promoter, specifically by changing the conformation of DNA to a state less conducive to transcription initiation. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could lead to the inhibition of OR52B2 expression through the alkylation of DNA bases within the OR52B2 promoter region, which might obstruct the binding of essential transcriptional machinery. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea might downregulate OR52B2 by depleting the pool of deoxyribonucleotide triphosphates, leading to a general attenuation of DNA synthesis required for gene transcription, including that of OR52B2. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein could lead to the downregulation of OR52B2 by inducing demethylation of cytosine residues within the promoter region of the gene, thereby disrupting the recruitment of DNA-binding proteins necessary for gene activation. | ||||||